Key result
Beta-blockers are tolerated in over 90% of patients with stable chronic heart failure if introduced gradually, resulting in consistent improvements in left ventricular function.
Why the study?
Does beta-blockers improve outcomes in patients with chronic heart failure?
Does beta-blockers improve outcomes in patients with chronic heart failure?
This review highlights the paradigm shift in heart failure management, where beta-blockers, once considered harmful, are now supported by compelling evidence for prognostic benefits.
Supports gradual beta-blocker initiation in stable HF; leaves open definitive outcome benefits pending prospective trials.
No takes yet. Share an insight, caveat, or question.
C.H. Davies (1999) conducted an editorial in Heart failure. Beta-blockers was evaluated. Beta-blockers are tolerated in over 90% of patients with stable chronic heart failure if introduced gradually, resulting in consistent improvements in left ventricular function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: